MV-LASV
V182-001
Phase 1 mab completed
Quick answer
MV-LASV for Lassa Virus Infection is a Phase 1 program (mab) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Harmony Biosciences Holdings
- Indication
- Lassa Virus Infection
- Phase
- Phase 1
- Modality
- mab
- Status
- completed